Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Dangor, Ziyaad ^a   Lala, Sanjay G ^a   Cutland, Clare L ^a   Koen, Anthonet ^a   Jose, Lisa ^a   Nakwa, Firdose ^a   Ramdin, Tanusha ^a   Fredericks, Joy ^a   Wadula, Jeannette ^a   Madhi, Shabir A ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ZIDOVUDINE;

ANTIBODY SCREENING; ARTICLE; BACTERIUM CULTURE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; EARLY ONSET DISEASE; FATALITY; FEMALE; GROUP B STREPTOCOCCAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INCIDENCE; INFANT; INOTROPISM; LATE ONSET DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICAN; BLACK PERSON; COMPARATIVE STUDY; COMPLICATION; HEALTH SURVEY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INFANT, NEWBORN, DISEASES; NERVOUS SYSTEM DISEASES; NEWBORN; PATHOGENICITY; PREGNANCY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SOUTH AFRICA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS SP. 'GROUP B';

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; NERVOUS SYSTEM DISEASES; POPULATION SURVEILLANCE; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84927549642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123014     Document Type: Article

References (43)

1. Oestergaard MZ, Inoue M, Yoshida S, Mahanani WR, Gore FM, Cousens S, et al. Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities. PLOS Med. 2011; 8(8):e1001080. doi: 10.1371/journal.pmed.1001080 PMID: 21918640
2. Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA, et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis. 2014; 14(8):731-41. doi: 10.1016/S1473-3099(14)70804-7 PMID: 24974250
3. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011; 30(11):937-41. doi: 10.1097/INF.0b013e318223bad2 PMID: 21654548
4. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011; 364(21):2016-25. doi: 10.1056/NEJMoa1005384 PMID: 21612470
5. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013; 31 Suppl 4:D20-6. doi: 10.1016/j.vaccine.2012.11.056 PMID: 23219695
6. Levent F, Baker CJ, Rench MA, Edwards MS. Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J. 2010; 29(11):1009-12. doi: 10.1097/INF.0b013e3181e74c83 PMID: 20555292
7. Edwards MS, Rench MA, Haffar AA, Murphy MA, Desmond MM, Baker CJ. Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr. 1985; 106(5):717-22. PMID: 3889248
8. Wald ER, Bergman I, Taylor HG, Chiponis D, Porter C, Kubek K. Long-term outcome of group B streptococcal meningitis. Pediatrics. 1986; 77(2):217-21. PMID: 3511445
9. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001; 323(7312):533-6. PMID: 11546697
10. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, et al. Long-term Outcomes of Group B Streptococcal Meningitis. Pediatrics. 2012; 130(1):e8-e15. doi: 10.1542/peds.2011-3453 PMID: 22689869
11. Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G, Mokhachane M, et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003; 23(1):15-23. PMID: 12648320
12. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012; 55(1):91-102. doi: 10.1093/cid/cis395 PMID: 22523262
13. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AKM, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012; 379(9815):547-56. doi: 10.1016/S0140-6736(11)61651-6 PMID: 22226047
14. National Department of Health. The National Antenatal Sentinel HIV and Syphilis Prevalence Survey. South Africa: National Department of Health; 2011. p. 12.
15. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics. 2010; 126(3):23.
16. National Department of Health. Clinical Guidelines: PMTCT (Prevention of Mother-to-Child Transmission). Pretoria: National Department of Health, South Africa; 2010.
17. National Department of Health. The South African Antiretroviral Treatment Guidelines, PMTCT Guidelines: Revised March 2013. South Africa: Department of Health; 2013. p. 8.
18. Glascoe FP, Byrne KE, Ashford LG, Johnson KL, Chang B, Strickland B. Accuracy of the Denver-II in developmental screening. Pediatrics. 1992; 89(6 Pt 2):1221-5. PMID: 1375732
19. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics. 1992; 89(1):91-7. PMID: 1370185
20. Kwatra G, Adrian PV, Shiri T, Buchmann EJ, Cutland CL, Madhi SA. Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy. PLOS One. 2014; 9(6): e98778. doi: 10.1371/journal.pone.0098778 PMID: 24979575
21. Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, et al. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci). J Clin Microbiol. 2011; 49(4):1475-82. doi: 10.1128/JCM.02365-10 PMID: 21325542
22. Poyart C, Tazi A, Reglier-Poupet H, Billoet A, Tavares N, Raymond J, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol. 2007; 45(6):1985-8. PMID: 17376884
23. District Research Committee. Birth statistics. Johannesburg: Johannesburg Health District. Gauteng Department of Health; 2014.
24. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59(RR-10):1-36. PMID: 21088663
25. Haffejee IE, Bhana RH, Coovadia YM, Hoosen AA, Marajh AV, Gouws E. Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa. J Infect. 1991; 22(3):225-31. PMID: 2071904
26. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000; 342(1):15-20. PMID: 10620644
27. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011; 30(1):45-51. doi: 10.1097/INF.0b013e3181ecbf7e PMID: 21173675
28. Landes M, van Lettow M, Chan AK, Mayuni I, Schouten EJ, Bedell RA. Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PLOS One. 2012; 7(10): e47337. doi: 10.1371/journal.pone.0047337 PMID: 23082157
29. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014; 176 (1):11-22. doi: 10.1111/cei.12251 PMID: 24325737
30. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011; 305 (6):576-84. doi: 10.1001/jama.2011.100 PMID: 21304083
31. World Health Organization. IMCI Integrated Mangement of Childhood Illness. In: Department of Child and Adolescent Health and Development, editor. Geneva, Switzerland: World Health Organization; 2005.
32. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLOS One. 2011; 6(3):e17861. doi: 10.1371/journal.pone.0017861 PMID: 21445302
33. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis. 2000; 30(2):276-81. PMID: 10671328
34. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008; 299(17):2056-65. doi: 10.1001/jama.299.17.2056 PMID: 18460666
35. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLOS One. 2011; 6(3).
36. Lamagni TL, Keshishian C, Efstratiou A, Guy R, Henderson KL, Broughton K, et al. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis. 2013; 57(5):682-8. doi: 10.1093/cid/cit337 PMID: 23845950
37. Fluegge K, Wons J, Spellerberg B, Swoboda S, Siedler A, Hufnagel M, et al. Genetic differences between invasive and noninvasive neonatal group B streptococcal isolates. Pediatr Infect Dis J. 2011; 30(12):1027-31. doi: 10.1097/INF.0b013e31822a2a1f PMID: 21775921
38. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013; 31 Suppl 4:D52-7. doi: 10.1016/j.vaccine.2013.02.029 PMID: 23973347
39. Eyre JA. Development and plasticity of the corticospinal system in man. Neural Plast. 2003; 10(1-2):93-106. PMID: 15152985
40. Steinhoff MC. Assessments of vaccines for prenatal immunization. Vaccine. 2013; 31 Suppl 4:D27-30. doi: 10.1016/j.vaccine.2013.02.031 PMID: 23973343
41. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014; 384(9953):1521-8. doi: 10.1016/S0140-6736(14)60686-3 PMID: 25037990
42. Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014; 371(10):918-31. doi: 10.1056/NEJMoa1401480 PMID: 25184864
43. Heyderman R, French N, Madhi S, Cutland C, Ngwira B, Mboizi R, et al. Safety and Immunogenicity of Investigational Group B Streptococcus Trivalent Polysaccharide-Conjugate Vaccine in HIV-infected and Uninfected Pregnant African Women and Newborns. European Society for Paediatric Infectious Diseases; Dublin, Ireland; 2014.